Regional distribution of nicotinic receptor subunit mRNAs in human brain: Comparison between Alzheimer and normal brain

Molecular Brain Research

Volumn 66, Issue 1-2, 1999, Pages 94-103

  Hellström Lindahl, Ewa ^a   Mousavi, Malahat ^a   Zhang, Xiao ^a   Ravid, Ritva ^b   Nordberg, Agneta ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NETHERLANDS BRAIN BANK   (Netherlands)

Author keywords

Alzheimers's disease; Human brain; MRNA; Nicotinic acetylcholine receptor; RT PCR

Indexed keywords

ALPHA BUNGAROTOXIN; EPIBATIDINE; IODINE 125; MESSENGER RNA; NICOTINIC RECEPTOR; TRITIUM;

AGED; ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; BINDING SITE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; NEUROLOGIC DISEASE; NEUROTRANSMISSION; PRIORITY JOURNAL; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING, COMPETITIVE; BRAIN CHEMISTRY; BUNGAROTOXINS; CEREBELLUM; FEMALE; HIPPOCAMPUS; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; PEPTIDYLPROLYL ISOMERASE; PYRIDINES; RECEPTORS, NICOTINIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TEMPORAL LOBE; TRITIUM;

EID: 0345434817     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00030-3     Document Type: Article

References (47)

1. H. Braak, E. Braak, Evolution of the Neuropathology of AD, Acta Neurol. Scand. Suppl., 1996, 3-12.
2. 125I ]-α-bungarotoxin binding in human postmortem brain J. Comp. Neurol. 387:1997;385-398.
3. Chromczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
4. Court J., Clementi F. Distribution of nicotinic subtypes in human brain. Alzheimer Dis. Assoc. Disord. 9(2):1995;6-14. Suppl.
5. Davies P., Feisullin S. Postmortem stability of α-bungarotoxin binding sites in mouse and human brain. Brain Res. 216:1981;449-454.
6. Donnelly-Roberts D., Xue J., Arneric S., Sullivan J. In vitro neuroprotective activator (ChCA) ABT-418. Brain Res. 719:1996;36-44.
7. Elliott K.J., Ellis S.B., Berckhan K.J., Urrutia A., Chavez-Noriega L.E., Johnson E.C., Velicelebi G., Harpold M.M. Comparative structure of human neuronal α2-α7 and β2-β4 nicotinic acetylcholine receptor subunits and functional expression of the α2, α3, α4, α7, β2 and β4 subunits. J. Mol. Neurosci. 7:1996;217-228.
8. 3H ] nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal J. Neurochem. 47:1986;1948-1954.
9. Gerzanich W., Peng X., Wang F., Wells G., Anand R., Fletcher S., Lindstrom J. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 48:1995;774-782.
10. Gopalakrishnan M., Monteggia L.M., Anderson D.J., Molinari E.J., Piattoni-Kaplan M., Donelly-Roberts D., Arneric S.P., Sullivan J.P. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine α4β2 receptor. J. Pharmacol. Exp. Ther. 276:1996;289-297.
11. Gotti C., Fornasari D., Clementi F. Human neuronal nicotinic receptors. Progr. Neurobiol. 53:1997;199-237.
12. Gray R., Rajan A., Radcliffe K., Yakehiro M., Dani J. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 383:1996;713-716.
13. Hellström-Lindahl E., Zhang X., Nordberg A. Expression of nicotinic receptor subunit mRNAs in lymphocytes from normal and patients with Alzheimer's disease. Alzheimer's Res. 3:1997;29-36.
14. Hellström-Lindahl E., Gorbounova O., Seiger Å., Mousavi M., Nordberg A. Regional distribution of nicotinic receptors during prenatal development of human brain and spinal cord. Dev. Brain Res. 108:1998;147-160.
15. 3H ]epibatidine binding to nicotinic cholinergic receptors in rat and human brain Mol. Pharmacol. 48:1995;280-287.
16. Kellar K.J. Epibatidine: its pharmacological actions and utility for studing neuronal nicotinic receptors. Neurotransmissions. 11:1995;1-5.
17. Kihara T., Shimohama S., Sawada H., Kimura J., Kume T., Kochiyama H., Maeda T., Akaike A. Nicotinic receptor stimulation protects neurons against β amyloid toxicity. Ann. Neurol. 42:1997;159-163.
18. Lang W., Henke H. Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients. Brain Res. 267:1983;271-280.
19. Liu C., Nordberg A., Zhang X. Differential co-expression of nicotinic acetylcholine receptor α4 and β2 subunit genes in various regions of rat brain. NeuroReport. 7:1996;1645-1649.
20. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
21. 3H ]epibatidine Brain Res. 801:1998;143-149.
22. A. Marutle, U. Warpman, N. Bogdanovic, L. Lannfelt, A. Nordberg, Deficits in neuronal nicotinic receptors in Alzheimer patients with the swedish APP 670/671 mutation, J. Neurochem., 1999, in press.
23. McGehee D.S., Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57:1995;521-546.
24. Mc Khann G., Drachman D., Folstein M., Katzman R., Prince D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA Work Group under the auspices of department of health and human services task forces on Alzheimer's disease. Neurology. 34:1984;939-944.
25. Miao H., Liu C., Bishop K., Gong Z.-H., Nordberg A., Zhang X. Nicotine exposure during a critical period of development leads to persistent changes in nicotinic acetylcholine receptors of adult rat brain. J. Neurochem. 70:1998;752-762.
26. Mirra S.S., Heyman A., Mc Keel D., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The consortium to establish a registry for Alzheimer's disease (CERAD): Part II. Standardization of the neuropatholic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
27. 3H -acetylcholine binding sites in the frontal cortex of Alzheimer brains Neurosci. Lett. 72:1986;115-119.
28. A. Nordberg, B. Winblad, Brain nicotinic and muscarinic receptors in normal aging and dementia, in: A. Fisher, I. Hanin, C. Lachman (Eds.), Alzheimer's and Parkinson's Diseases, Plenum, New York 1986, pp. 95-108.
29. Nordberg A., Adem A., Hardy J., Winblad B. Change in nicotinic receptor subtypes in temporal cortex of Alzheimers brains. Neurosci. Lett. 86:1988;317-321.
30. 11C -nicotine in brain of Alzheimer patients as visualized by positron emission tomography J. Neural Transm. 2:1990;215-224.
31. Nordberg A. Neuroreceptor changes in Alzheimer disease. Cerebrovasc., Brain Metab. Rev. 4:1992;303-328.
32. Nordberg A., Alafuzoff I., Winblad B. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. J. Neurosci. Res. 31:1992;103-111.
33. 11C ]nicotine in normal and Alzheimer brains - in vivo assessment using positron emission tomography Alzheimer Dis. Assoc. Disord. 9:1995;21-27.
34. Perry E.K., Morris C.M., Court J.A., Cheng A., Fairbairn A.F., Mc Keith I.G., Irving D., Brown A., Perry R.H. Alternation in nicotine binding sites in Parkinsons's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience. 64:1995;385-395.
35. 3H ]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study J. Pharmacol. Exp. Ther. 275:1995;1030-1034.
36. Rinne J.O., Myllykylä T., Lönnberg P., Marjamäki P. A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease. Brain Res. 547:1991;167-170.
37. Rubboli F., Court J.A., Sala C., Morris C., Chini B., Perry E., Clementi F. Distribution of nicotinic receptors in the human hippocampus and thalamus. Eur. J. Neurosci. 6:1994;1596-1604.
38. Sargent P.B. The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16:1993;403-443.
39. Schröder H., de Vos R.A.I., Jansen E.N.H., Birtsch Ch., Wevers A., Lobron Ch., Nowacki Ch.S., Schröder R., Maelicke A. Gene expression of the nicotinic acetylcholine receptor α4 subunit in the frontal cortex in Parkinson's disease patients. Neurosci. Lett. 187:1995;173-176.
40. Shimohama S. Nicotinic agonists prevent neuronal cell death by glutamate and amyloid beta protein. Neurobiol. Aging. 17:1996;S40.
41. 3H ]epibatidine in vitro autoradiography Neuroscience. 85:1998;1121-1133.
42. Sugaya K., Giacobini E., Chiappinelli E.V.A. Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease. J. Neurosci. Res. 27:1990;349-359.
43. Warpman U., Nordberg A. Epibatidine and ABT-418 reveal selective losses of α4β2 nicotinic receptors in Alzheimer brains. NeuroReport. 6:1995;2419-2423.
44. Wevers A., Jeske A., Lobron Ch., Birtsch Ch., Heinemann S., Maelicke A., Schröder R., Schröder H. Cellular distribution of nicotinic acetylcholine receptor subunit mRNAs in the human cerebral cortex as revealed by non-isotopic in situ hybridization. Mol. Brain Res. 25:1994;122-128.
45. Wevers A., Sullivan J.P., Giordano T., Birtsch Ch., Monteggia L.M., Nowacki S., Arneric S., Schröder H. Cellular distribution of the mRNA for the α7 subunit of the nicotinic acetylcholine receptor in the human cerebral cortex. Drug Dev. Res. 36:1995;103-110.
46. Whitehouse P.J., Martino A.M., Antuono P.G., Lowenstein P.R., Coyle J.T., Price D.L., Kellar K. Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res. 371:1986;146-151.
47. Zhang X., Gong Z.-H., Hellström-Lindahl E., Nordberg A. Regulation of α4β2 nicotinic acetylcholine receptors in M10 cells following treatment with nicotinic agents. NeuroReport. 6:1995;313-317.